Infectious Diseases 1401 - Infectious Disease Alert - Jan 01, 2010

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Stanford
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Timothy Jenkins, MD
Assistant Professor of Medicine
University of Colorado
Denver Health Sciences Center

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor, Updates
Section Editor, HIV

Associate Editors
Dean L. Winslow, MD, FACP, FIDSA
Chief
Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine
Section Editor, HIV

Jessica Song, MA, PharmD
Assistant Professor
Pharmacy Practice
University of the Pacific
Stockton, CA
Pharmacy Clerkship and Coordinator
Santa Clara Valley Medical Center
Section Editor, Managed Care

Authors
Pamela Tien, PharmD Candidate
Jonathan Nieh, PharmD Candidate

Subjects:

  • New DHHS Guidelines for Antiretroviral Therapy
  • Alternative Therapeutic Options for Pandemic Influenza A H1N1
  • Should Patients with Prosthetic Joints Routinely Receive Antibiotic Prophylaxis When Undergoing Dental Pocedures?
  • Updates

Objectives:

  • discuss the diagnosis and treatment of infectious diseases
  • explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Financial Disclosure:

Infectious Disease Alert's Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker’s bureau for Merck, Pfizer, Wyeth, Ortho-McNeil (J&J), Schering-Plough, and Cubist, does research for the National Institute of Health, and is an advisory board member for Schering-Plough, Ortho-McNeil (J&J), and Cepheid.

Peer Reviewer Timothy Jenkins, MD, Associate Editor, Jessica C. Song, MA, PharmD, and Authors Pamela Tien, PharmD Candidate, and Johnathan Nieh PharmD Candidate, reports no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company related to this field of study.

Updates Author Carol A. Kemper, MD, FACP, does research for GSK Pharmaceuticals, Abbott Laboratories, and Merck.

Associate Editor Dean L. Winslow, MD, FACP, FIDSA, serves as a consultant for Siemens Diagnostics, and is on the speaker's bureau for GSK and Cubist.

Copyright 2010 AHC Media. All rights reserved.